Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 419 of 6351
-
New combo pill aims to extend life in tough bile duct cancer
Disease control Recruiting nowThe object of this trial is to evaluate the efficacy of D07001-softgel capsules + capecitabine compared with placebo + capecitabine by overall survival (OS). Eligible patients with advanced biliary tract cancer (BTC) will be randomized (1:1:1) to receive either 60 mg D07001-soft…
Phase 3 • Sponsor: InnoPharmax Inc. • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Radiosurgery zaps cancer pain when opioids fail
Symptom relief Recruiting nowThe investigators propose to conduct a study in medically refractory cancer pain patients utilizing radiosurgery to ablate the pituitary hypophysis, as well as neuromodulate the centromedian and parafascicular complexes within the thalami - the so-called triple target. This invol…
Sponsor: Jonsson Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
Could a simple ear device ease fibromyalgia pain and fatigue?
Symptom relief Recruiting nowFibromyalgia syndrome (FMS) is a chronic pain condition characterized by widespread pain, fatigue, sleep disturbances, cognitive symptoms, and autonomic dysfunction, significantly impairing quality of life. Increasing evidence suggests that, beyond central pain dysregulation, pat…
Sponsor: University of Roma La Sapienza • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
New drug cocktail aims to tackle tough pancreatic cancer
Disease control Not yet recruitingThis is a Phase Ib/II clinical study aimed to evaluate the tolerability of becotatugvedotin in combination with gemcitabine, determine the clinically recommended dose for the combination regimen, and assess the efficacy and safety of becotatugvedotin combined with gemcitabine in …
Phase 1/2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
A tiny chest incision, a beating heart: can a new technique fix leaky valves without open surgery?
Disease control Recruiting nowThe purpose of this study is to assess the safety and effectiveness (usefulness) of an investigational technique used to repair the mitral valve for patients with mitral regurgitation due to a defective valve leaflet. This procedure is called trans-ventricular off-pump mitral val…
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a new asthma inhaler match the standard of care?
Disease control Recruiting nowA multicenter, randomized, double-blind, active-controlled, parallel-group Phase III clinical study comparing the efficacy and safety of Beclometasone Dipropionate and Formoterol Inhalation Aerosol versus FOSTER® in patients with asthma. The purpose of this study is to compare th…
Phase 3 • Sponsor: Lunan Better Pharmaceutical Co., LTD. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can a custom AI storybook tame Kids' dental fear?
Symptom relief Recruiting nowDental anxiety and uncooperative behavior frequently interfere with the successful delivery of dental treatment in children and may increase the need for pharmacological behavior management. Storytelling is a widely used non-pharmacological behavior guidance technique that can im…
Sponsor: Eskisehir Osmangazi University • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
Could a cancer drug make stem cell transplants safer for sickle cell patients?
Disease control Recruiting nowThis trial will determine whether adding ruxolitinib to a reduced intensity conditioning (RIC) regimen reduces the rate of graft failure following haploidentical (haplo) hematopoietic cell transplant (HCT) for children and young adults with sickle cell disease (SCD). This study …
Phase 1/2 • Sponsor: Arkansas Children's Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New drug shows promise for rare genetic disorder in kids
Disease control Recruiting nowThis Phase 3, open-label extension, multicenter study will evaluate long-term safety, tolerability and efficacy of NNZ-2591 in pediatric participants with Phelan- McDermid Syndrome.
Phase 3 • Sponsor: Neuren Pharmaceuticals Limited • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Pill form chemo shows promise for older lung cancer patients in new trial
Disease control Not yet recruitingThis study is a multicenter, single-arm Phase II clinical trial, aiming to explore the safety and preliminary efficacy of oral paclitaxel solution combined with immune checkpoint inhibitors as a neoadjuvant regimen in elderly patients aged 70-85 years with non-small cell lung can…
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New hope for lupus patients with dangerous low platelet counts
Disease control Recruiting nowThe goal of this clinical trial is to learn if sirolimus, added to standard background therapy (corticosteroids and hydroxychloroquine), works to treat systemic lupus erythematosus-associated immune thrombocytopenia (SLE-ITP) in adults aged 18 to 65 years. The study also aims to …
Phase 2/3 • Sponsor: Chinese SLE Treatment And Research Group • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for breast cancer patients: experimental drug combo enters Mid-Stage trial
Disease control Recruiting nowTo evaluate the efficacy and safety of Culmerciclib combined with fulvestrant compared with investigator-selected CDK4/6 inhibitors combined with fulvestrant in patients with HR-positive/HER2-negative breast cancer who have progressed after first-line endocrine therapy
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New drug combo aims to stop aggressive breast cancer from returning
Disease control Recruiting nowThis study is a prospective, multicenter, phase II clinical trial designed to evaluate the efficacy and safety of postoperative chemotherapy combined with QL1706 in patients with high-risk triple-negative breast cancer. After enrollment, participants will receive 8 cycles of che…
Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a common drug help fight rare bone cancers?
Disease control Recruiting nowEwing sarcoma (EWS) and osteosarcoma primarily affect adolescents and young adults. Common treatments include chemotherapy, surgery and radiation, however, there have been few recent advancements in the standard of care. By incorporating eflornithine (DFMO) as an additional thera…
Phase 2 • Sponsor: Milton S. Hershey Medical Center • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Common antibiotic could help stroke patients recover
Disease control Recruiting nowThe aim of this study is to assess the efficacy and safety of minocycline in improving functional outcome among patients with acute ischaemic stroke receiving intravenous thrombolysis.
Phase 3 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Supercharged immune cells take on Hard-to-Treat cancers
Disease control Recruiting nowThe allogeneic TCR-enhanced Vδ2 T cell product is a novel genetically engineered cellular therapeutic. By engineering a specific BTN protein-binding moiety on its cell surface, this product harnesses the intrinsic tumoricidal potential of endogenous Vδ2 T cells and augments BTN p…
Phase 1/2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Could a diabetes drug help smokers kick the habit and avoid weight gain?
Symptom relief Recruiting nowThis multi-site clinical trial will generate data on the efficacy of tirzepatide for smoking cessation and associated outcomes (e.g., post-cessation weight gain) in treatment-seeking people who smoke (PWS) with overweight or obesity. A sample of 300 treatment-seeking people who s…
Phase 2 • Sponsor: University of Southern California • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
New Antibody-Drug combo shows promise for Hard-to-Treat breast cancer
Disease control Recruiting nowThis phase II trial tests how well ARX788 works in treating patients diagnosed with HER2-low, locally advanced unresectable or metastatic breast cancer. ARX788 is an antibody-drug conjugate (ADC) that is given by infusion (diluted and injected slowly into veins). Antibodies are p…
Phase 2 • Sponsor: Laura Huppert, MD, BA • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New hope for multiple myeloma: phase 3 trial launches
Disease control Not yet recruitingThe purpose of this study is to evaluate how well IBI3003 works when compared with the investigator's choice regimen (DPd or PVd)
Phase 3 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New chemo cocktail aims to fight childhood germ cell tumors that return
Disease control Recruiting nowTo collect information about treatment outcomes in pediatric and adolescent patients with relapsed/refractory germ cells tumors who receive GemDMC with an ASCT.
Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC